Drug Research

When Willus Fisher, a doctorate candidate at the University of California, Santa Barbara, was instructing students in pharmacology, he encountered an issue that has persisted for the past four to five years. Fisher made this observation when he was...

It is noteworthy that the pharmaceutical industry is gradually moving toward what are referred to as biologics, or biological medications. The truth is that the prior generation of pharmaceuticals made by chemical synthesis was essentially one size fits all....

Innovative drug methods are causing a big change in the biotech industry, especially in cancer, where complicated diseases are treated. This change includes personalized medicines, treatments that work together, and new ways to get products to patients. As the...

Small Molecule API Market Size, Share, and Growth Analysis The world's healthcare sector is experiencing an increase in demand for high-quality, dependable pharmaceutical ingredients, led by the quickening pace of progress in small molecule Active Pharmaceutical Ingredients (APIs). Being the...

Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than the discovery of novel molecules.   Advances in specialty intermediates, which are essential for repurposing...

The need to improve the effectiveness, safety, and accessibility of drugs drives research and innovation in the ever-evolving pharmaceutical industry.  The problem of solubility and bioavailability, which affect how well a medication reaches its intended biological target after oral...

Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC). Data from the B1 cohort of the trial showed encouraging antitumor efficacy in highly pre-treated...